(esmo), a leading global full-service systems integrator, developer, and supplier of innovative and advanced automation ...
TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck cancer setting Financial visibility confirmed into Q4 2025 Strasbourg, ...